Group 1 - The core viewpoint of the report indicates that the pharmaceutical and communication sectors performed well during the period, while the overall market saw declines in major indices [2][8][13] - The report highlights that the average return of actively managed equity funds decreased by 0.26%, while actively managed bond funds saw a slight increase of 0.08% [2][16] - The report notes that the long-term pure bond funds outperformed other bond categories, with an average return of 0.15% for the period [16][17] Group 2 - The report identifies that the pharmaceutical sector has shown strong performance, with several actively managed equity funds focused on this sector achieving high returns [14][15] - The report provides a detailed analysis of various fund categories, indicating that the average return for QDII funds varied significantly, with energy commodity QDII funds leading at 4.54% [18][20] - The report emphasizes that the average return for the equity funds in the Greater China region was notably high at 33.16% for the year [18][20]

Core Insights - The report indicates that the Shanghai Composite Index rose by 1.40% and the Shenzhen Component Index increased by 1.25% during the period from June 30 to July 4, 2025, with the steel and building materials sectors performing particularly well [2] - Various types of funds experienced gains, with actively managed equity funds rising by 1.82%, mixed funds increasing by 1.25%, and bond funds up by 0.17% [2] Equity Sector Performance - The steel sector showed strong performance, with the majority of the Shenwan first-level industries experiencing gains, particularly in steel and building materials [8] - Over the last 12 periods, banks and comprehensive sectors have also performed well [8] Fund Performance - Actively managed equity funds focusing on the pharmaceutical and biotechnology sectors performed notably well during this period [11] - The top-performing representative actively managed equity funds included: - Yongying Medical Health A with a return of 15.52% - Hongtu Innovation Healthcare Stock with a return of 13.39% [12] - The top-performing representative index equity funds included: - Hong Kong Stock Connect Innovative Drug ETF with a return of 7.58% - Huatai-PB Hang Seng Innovative Drug ETF with a return of 6.21% [12] Fixed Income Sector Performance - The bond market indices showed positive movement, with the China Convertible Bond Index rising by 1.21% and convertible bond funds increasing by 0.91% [14] - The average return for convertible bond funds this year stands at 7.86% [16] QDII Fund Performance - Various QDII funds showed positive performance, particularly in alternative asset categories, with energy commodity QDII funds rising by 2.08% and gold-related QDII funds increasing by 1.62% [17] - The top-performing QDII funds included: - E Fund Global Pharmaceutical Industry RMB A with a return of 6.53% - Huatai-PB Hang Seng Innovative Drug ETF with a return of 5.47% [19]